Key result
Perioperative acute renal failure remains a major cause of morbidity and mortality in cardiac and vascular surgery, and current intraoperative renal protective strategies lack scientific validation.
Perioperative acute renal failure remains a persistent and severe complication of major cardiac and vascular surgeries with profound impacts on mortality, yet effective preventive strategies remain unvalidated.
Answers are grounded in this paper and cite their sources.
Unvalidated renal strategies warrant clinical caution in cardiac/vascular surgery; leaves open identification of effective interventions via prospective trials.
Introduction Although significant advances in the perioperative and intraoperative care of patients undergoing major vascular and cardiac surgery have been achieved over the last several decades, the occurrence of perioperative acute renal failure (PARF) continues to plague the postoperative course of these patients. The magnitude of this problem is substantial when it occurs because it is associated with marked increases in morbidity and mortality. Anesthesiologists often use intraoperative strategies with the intention of providing renal protection; however, no substantive scientific evidence has validated any such intervention. Consequently, the commonly used practices aimed at preserving the kidney are based on small studies, anecdotal information, or personal experience. In fact, the incidence of PARF in this population and its impact on outcome have changed little in the last 20 years. The purpose of this article is to summarize the statistics regarding the incidence and consequences of PARF, review what is known about the pathophysiology of PARF, evaluate the techniques currently used to provide renal protection, and scan the horizon for evidence of more effective therapies to prevent this complication in the future. Incidence and Impact Identifying the exact incidence of PARF is rendered difficult by lack of consensus of definition. In one systematic review of 28 studies examining perioperative risk factors for PARF, no two studies used the same criteria to define renal failure. 1 Whatever definition is used, however, it is evident that the problem is far from trivial. Several large studies examined the statistical dimensions of this persistent issue, obtaining similar results. The best studied and most uniform population consists of patients undergoing cardiopulmonary bypass (CPB). Although estimates of PARF in this population vary from 1–15%, even 1% of the roughly 600,000 CPB cases done annually represents 6,000 new cases of renal failure, constituting a serious public health concern. Conlon and colleagues 2 studied 2,843 consecutive adults undergoing CPB, of whom 7.9% experienced renal dysfunction and 0.7% required dialysis. In Mangano and associates 3 prospective observational study of 2,222 adults undergoing CPB, 7.7% of patients experienced renal failure and 1.4% needed dialysis. Chertow and others, 4 using a data base of 43,643 patients who had undergone CPB, found a 1.1% incidence of PARF requiring dialysis. The effect of PARF on mortality in these studies is profound. In Conlon and colleagues's study, mortality in the absence of renal failure was 1% but rose to 14% with renal dysfunction and to 28% if dialysis had to be instituted. Similarly, Mangano and coworkers found a mortality of 0.9% without renal failure, 19% with renal failure, and 63% in patients requiring dialysis. Chertow and associates also reported 63.7% mortality when dialysis was needed, although the mortality without renal failure was higher than in the other studies at 4.3%. Recent data regarding thoracic aortic surgery are less voluminous but no more reassuring. Godet and others 5 reported on 475 consecutive thoracoabdominal aneurysm (TAA) repairs over a 12-year period. Renal failure occurred in 25% and dialysis was needed in 8%, but the mortality of these groups was not reported. Kashyap and associates 6 studied 183 TAA repairs, and found an 11.5% incidence of renal failure and 2.7% rate of dialysis. The odds ratio for death in the first 30 days postoperatively was 9.2 for the 11.5% of patients in whom renal failure developed compared with those who did not. The data for abdominal aortic surgery are even scantier. Braams and associates 7 reported a 69% mortality in 42 patients who experienced renal failure, requiring dialysis after abdominal aortic aneurysm (AAA) repair. Johnston, 8 in a study of 666 unruptured AAA repairs, reported a 5.4% incidence of PARF, with 0.6% requiring dialysis. The uniformly gloomy statistics once renal failure is established are not unique to the surgical population. Levy and others 9 published a case-control study in which 183 patients who experienced contrast media–associated renal failure were compared with 174 matched controls. The mortality in the renal failure group was 34% compared with 7% in the control group. The authors concluded that renal failure increases the risk of nonrenal complications that lead to death. These statistics beg for the development of strategies to protect the kidneys from perioperative injury; unfortunately, to date, no such strategy has been shown to be effective. The Population at Risk Risk factors for postoperative PARF have been intensively studied. The aforementioned systematic review of 28 studies found that preoperative renal dysfunction was the single consistent predictor of postoperative renal failure. The nature of the surgical procedure also significantly affects the incidence of PARF; the highest incidence occurs after CPB and vascular surgeries involving the aorta. The unifying theme in pathophysiology of PARF is renal ischemia, which is responsible for the bulk of PARF cases. PARF is commonly the consequence of more than one insult, and prerenal azotemia, which reflects renal hypoperfusion, is the most common predisposing factor. Hence, patients already suffering from a chronic ischemic state such as renal artery stenosis, volume depletion, or diabetes or a recent acute ischemic event such as hemorrhage or exposure to radiocontrast agents are more likely to suffer ARF when subsequently exposed to an intraoperative ischemic insult. Unfortunately, the patient population undergoing cardiac or aortic surgery also is characterized by high rates of diabetes, atherosclerotic disease, and recent exposure to radiocontrast dye as well as having a high incidence of preexisting renal insufficiency. Many other conditions may predispose the kidneys to ischemic injury including sepsis, cirrhosis, jaundice, hepatorenal syndrome, congestive heart failure, hemorrhage, shock, malignant hypertension, preeclampsia and toxemia, sickle cell anemia, collagen vascular diseases, and multiple myeloma. Many drugs also may potentiate the risk of ischemic renal injury through alterations in intrarenal hemodynamics, including angiotensin-converting enzyme inhibitors (ACEIs), nonsteroidal antiinflammatory drugs (NSAIDs), cyclosporine, tacrolimus, and amphotericin B. 10 Pathophysiology of Perioperative Acute Renal Failure To understand best the pathophysiology of PARF, it is worthwhile to review some aspects of renal physiology. The kidneys normally receive 25% of cardiac output, by far the organ with the most luxuriant blood flow per tissue mass. Most of this blood flow is delivered to the cortex to maximize glomerular filtration. Flow to the renal medulla is substantially less generous, a condition necessary to keep from “washing out” the medullary concentration gradient. 11 Yet the most energy-requiring segment of the nephron is the medullary thick ascending loop of Henle (mTAL), which is located in the outer medulla. The tubular cells of this segment are very rich in mitochondria, because they are responsible for the bulk of active chloride ion reabsorption. This combination of low flow and high metabolic demand in this segment renders the outer medulla chronically on the verge of hypoxia. In an elegant series of experiments, Brezis and colleagues 12,13 used sensitive Clark-type oxygen (O2) microelectrodes to measure cortical and medullary oxygen tensions in rat kidneys. Laser Doppler probes were placed in the cortex and medulla as well to measure regional blood flow. The authors demonstrated baseline partial pressure of O2 (PO2) levels of 10–20 mm Hg in the medulla and 40–50 mm Hg in the cortex. They then measured the effect of hypotension on tissue oxygenation by exposing the rats to controlled hemorrhage, aortic ligation, or sodium nitroprusside. They found that, whereas cortical PO2 fell, medullary PO2 levels paradoxically rose. They then demonstrated that this was not due to redistribution of blood flow to favor the medulla, because the laser Doppler probes showed no increase in medullary flow. Further, the phenomenon occurred even when all major vasodilators were blocked, strongly suggesting that the tissue PO2 rose not because of enhanced O2 delivery but because of decreased medullary O2 utilization. The authors hypothesized that medullary O2 utilization decreased as a result of a decrease in glomerular filtration rate (GFR) leading to a decrease in distal tubular reabsorptive work. They additionally suggested that intrarenal mediators might directly inhibit transport in the mTAL in response to decreased renal perfusion. Supporting these data was another series of experiments where the tissue PO2 response to administration of diuretics was measured. When furosemide, which is known to block the active chloride reabsorption in the mTAL, was given, there was no effect on cortical PO2, but medullary PO2 rose much as with hypotension. Similar experiments with the carbonic anhydrase inhibitor acetazolamide revealed an increase in cortical PO2 but no effect on medullary PO2, consistent with this drug's proximal tubular site of action. The broad conclusion drawn from these experiments was that medullary blood flow correlated poorly with tissue oxygenation and that medullary PO2 was largely a function of local O2 demand. It follows, then, that preventing injury to the vulnerable renal medulla should involve not only preservation of oxygen delivery but attenuation of medullary oxygen demand. This is in contrast to the general thrust of traditional renal protective strategies, which emphasized maximizing renal blood flow and maintaining urine output. These experiments demonstrated that medullary PO2 could be improved in the setting of both low urine output (hypotension) and high urine output (furosemide); oliguria might, up to a point, reflect intact endogenous renal protective mechanisms rather than stand as evidence of dysfunction or injury. The common practice of using a desired minimum urine output as an end point for renal protection may thus be misguided. The balance of oxygen supply and demand in the kidney is complicated by the fact that increasing renal blood flow also increases the volume of glomerular filtrate; this, in turn, may increase the oxygen demand of the kidney as more solute is delivered to the tubules for reabsorption, an energy-requiring process. Consequently, alterations in intrarenal regional blood flow distribution that promote cortical perfusion may significantly impair medullary blood supply. That is, if preglomerular capillary vasomotor tone is relaxed and postglomerular vasomotor tone is increased, the negative effects on the medulla will be twofold. Medullary blood flow will decrease as the result of postglomerular vasoconstriction, but medullary oxygen demand will increase because of the enhanced delivery of filtrate to the tubules. Thus, disturbances in intrarenal regional blood flow, even in the presence of relatively normal total renal blood flow, may lead to inadequate oxygen delivery in the medulla. Normal intrarenal vascular tone is characterized by a balance of the effects of vasodilatory substances, including nitric oxide (NO), urodilatin, kinins, and prostaglandin (PG) E2, and vasoconstrictors, notably endothelin, catecholamines, and angiotensin II. Adenosine, released in ischemic tissues as adenosine triphosphate (ATP) is used and broken down, has a vasoconstrictor effect in the renal cortex and a vasodilating effect in the medulla. Its net effect in the setting of decreased renal perfusion is thus to attenuate medullary hypoxia both by decreasing glomerular filtration and subsequent reabsorption and by enhancing medullary blood flow (Fig. 1). In the setting of ischemia, decreases in NO production occur, which may have a proinflammatory effect 14 and result in vasoconstriction. 15 The renal injury in myoglobinuria seen with rhabdomyolysis may be mediated, at least in part, by the NO scavenging effect of free myoglobin with resultant vasoconstriction. Normal vascular balance may be disrupted by exogenous substances such as NSAIDs, which decrease PGE2 production with resultant loss of its medullary vasodilating effect. 16 Radiocontrast nephropathy has been shown to be an ischemic renal injury, caused by a combination of intense medullary vasoconstriction and increased delivery of solute to the tubules as a result of osmotic diuresis. 17 Experiments in animals support a role for disturbed regulation of multiple vasoactive substances, including prostaglandins, angiotensin II, NO, endothelin, and adenosine, but to date human data are lacking to define a causative mechanism. 17Figure 1.: Schematic representation of the effects of adenosine on renal circulation. Note that the effect on A1 receptors is more prominent than on A2 receptors. O2 = oxygen; A1 = adenosine-1 receptor; A2 = adenosine-2 receptor; = renal blood = glomerular filtration = sodium = oxygen renal injury affects the tubules at the of the outer medulla, which the mTAL and the of the proximal 11 cell death is to be characterized both by and by or cell death. from and is characterized by a of These with loss of cell and of the by the loss of the of and the of such as on the cell These with to an response with of 20 then the tubular already filtrate flow and leading to tubular in turn, an increase in tubular pressure proximal to the with of filtrate the and proximal tubular injury 10 cell is also by through as also in cell but there is no and the resultant are by or also is in the where it likely a role in a normal tubular the is a loss of as the medullary by a in urine output as tubules and for Renal strategies to provide renal protection are largely based on anecdotal information, from or other and large have at preventing renal injury in the surgical The most commonly used techniques are and loop often in The and evidence for of these are The most in renal protection from the study of radiocontrast Although not the same as a surgical insult, radiocontrast dye in intrarenal hemodynamics, which lead to an ischemic injury to that by CPB or aortic of the only of these studies is that is effective at the rate of renal injury. The study of and colleagues compared with and in patients or undergoing Renal dysfunction occurred in of the 28% of the and of the group. The strategy of at 1 for the The study was on a small and to patients were or NSAIDs, the Further, in the of of preoperative is not a and is to be used for volume is a risk for PARF, and it is to exposing the patient to the ischemic insult. The use of to this is but there is no consensus as to the of artery over small studies in the of patients undergoing abdominal aneurysm concluded that, when was by a renal was studies in however, to support this study of patients undergoing abdominal aneurysm in whom were placed concluded that data from the were used to In the published its regarding the use of the of data use in patients undergoing aortic the authors concluded that patients with function undergoing aortic surgery could be with pressure the of studies, and studies, for patients with a less than with artery disease, or undergoing was The same the evidence regarding use in patients undergoing artery bypass and vascular In both of these evidence was to support use of artery a the role of for renal protection is The absence of data a effect on renal outcome has in the not its because urine output often is to increase with its already however, urine production may not with medullary by of an increase in renal cortical blood flow, leading to increased glomerular solute and urine output. 28 decreases intrarenal enhancing and glomerular flow. These effects likely increase renal medullary oxygen the other of and receptors not the and effect of this a effect of to be an of the in the proximal and 30 an effect decrease tubular and medullary oxygen Thus, the net effect of on renal medullary oxygenation is may also have cardiac effects such as and and it may inhibit and oxygen and in review of the regarding the use of in the perioperative concluded that the studies to date to a in preventing renal failure. In and coworkers adults with normal preoperative renal function who were and after cardiac surgery with of furosemide, or They found no renal protective from and a effect with The study is by small and only and urine to for renal injury. the administration of the study drugs well the acute ischemic insult, from the use of these drugs in this and colleagues cardiac surgical patients to receive or with of as a measure of tubular injury, they found marked in the group compared with the group. They concluded that renal tubular injury was by the most evidence the of renal was the and that in in in The that by to one receptors is rendered by these which not even for the of in as has been used in patients at high risk for is to provide by increasing tubular flow by filtrate volume through its osmotic effect. once in the it tubular cell by increasing tubular and decreasing to flow. The enhanced urine flow is to prevent tubular and the resultant renal injury from The of as a it in the setting of injury. studies the for the use of as a protective and studies protection of renal support a protective small prospective study with in patients undergoing aortic aneurysm found significantly less glomerular and tubular injury, as measured by and levels in the group. Although no large controlled studies in aortic or cardiac surgical patients have demonstrated these it is commonly in a single the of the in aortic surgery patients or in the CPB in cardiac is to of volume and to of The for use of as a renal is from the regarding the medullary hypoxia by reabsorptive in the Although the in are they have to be evidence in one problem may in is if are that well the surgical protective effects may be by the consequences of has vasodilatory and cortical This may result in medullary hypoperfusion, over a of may be more than It to use in a single the ischemic because the of should be to through the CPB or studies as a renal in surgical patients are but a of other studies in an to prevent radiocontrast This the aforementioned study of and in which was found to be to and and associates studied patients undergoing a of if the artery pressure was on heart The patients only with the in the was no the two groups in the in control patients and group patients required dialysis. In a similar study, and others patients with chronic renal of which were groups patients or they found that renal protection was in the patients but not in the in which the agents to The be with because the was for Renal substances not used but have been as renal in radiocontrast such as and known renal and the endogenous have renal vasodilating and and could provide renal protective of in patients after cardiac surgery some for this and coworkers found no and in a study of patients with chronic renal undergoing radiocontrast studies have been done in patients undergoing large are of this as a perioperative an endogenous renal also is an for maintaining intrarenal in the of an ischemic insult. and others 42 compared in with in patients with chronic renal undergoing radiocontrast rose more in the measured did not more data are required to the use of this as a renal is a and with that has based on the that it could renal perfusion without risk of the of renal perfusion may have the effect of increasing medullary oxygen demand by increasing active chloride and sodium reabsorption in the not to inhibit sodium reabsorption it have the net effect of increasing medullary oxygen demand. Although one small study in aortic surgery patients a more recent study demonstrated no effect on renal vascular Although is a and may it the effects of and a are needed to its as a renal is the only having been for the of Its lack of at or receptors it as an to It has been shown to blood pressure in a preserving renal perfusion and Its effects on sodium reabsorption in are and but may thus at least attenuate medullary oxygen demand enhancing supply. It may have a more effect in study of its use in a aortic has some but large prospective as a renal in have to be is to evaluate as a renal This endogenous has been demonstrated to from renal failure in studies, but currently no evidence its use on a which has been shown to attenuate injury, has also been shown to attenuate renal failure after injury of the kidney in In this an NO inhibitor the protective effect of suggesting that the protective effect of may be by the antiinflammatory and vasodilating effects of renal may be caused or by a effect on the renal with a intrarenal study using a of aortic surgery found a substantial effect in with an such an be found to be in it an however, the problem of hypotension might in Renal Although some of the strategies may be shown to have some in renal protection, it is that a recent of will That the of ischemic and adenosine receptors. the most recent and one that might be human experiments, is the that renal ischemic has been shown by several to protect the kidney from ischemic injury in In these experiments, of renal and a ischemic substantial protection from the renal injury seen in animals no Yet more is a that the effect of renal be by of In a series of experiments, and exposed rats to ischemic or adenosine a period. and for the and adenosine they were to that the renal protective effect is by the A1 adenosine the administration of a A1 did not block the renal protection by ischemic They also found that, although A2 receptors were not in renal protection, of receptors renal injury and of those receptors had renal protective The effect of adenosine may be through of as has been shown in or it may be an effect of preglomerular vasoconstriction with resultant decrease in glomerular solute delivery to the sodium reabsorption, and medullary oxygen These are of for several adenosine is an endogenous with which there is already experience. it is a currently that has all it is an with an use in patients could be This it an for use in The development of a also be a in renal protection This the of human studies of both and adenosine in of a of renal ARF after cardiac and aortic surgery continues to a the for morbidity and mortality are profound. The for and thus in techniques to this Unfortunately, little in its has been over the last decades, and renal protection strategies are of the effects of ischemic and the role of adenosine receptors provide however, and studies are strongly to the of these to patient
No takes yet. Share an insight, caveat, or question.
Nicholas Sadovnikoff (2001) conducted a review in Perioperative Acute Renal Failure (PARF). Renal protective strategies was evaluated. Perioperative acute renal failure remains a major cause of morbidity and mortality in cardiac and vascular surgery, and current intraoperative renal protective strategies lack scientific validation.
Synapse has enriched 10 related papers. Consider them for comparative context: